‘Treg’ cell therapy: bringing CAR-T to autoimmune disease
Bio Pharma Dive
AUGUST 16, 2022
At least seven companies, including five richly funded startups, are developing cell-based treatments for inflammatory conditions, making it one of biotech’s most competitive fields.
Let's personalize your content